Sven Klijn | Director, HEOR Evidence Acceleration & Innovation
Bristol Myers Squibb

Sven Klijn is Director at Bristol Myers Squibb in the Global HEOR Evidence Acceleration & Innovation group, where he leads the innovative modeling agenda in hematology and cell therapy. In addition, Sven has an active role in providing modeling and Generative AI education at international congresses. He has widely published on innovative methods, especially in the fields of survival extrapolation and Generative AI. Sven has a training in public health and health economics and previously had various roles in CROs related to health-economic modeling.